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doi:10.1016/j.jds.2011.02.001Abstract Background/purpose: In this in vitro study, we assessed the antifungal effect of
mouth rinses containing chlorhexidine and thymol.
Materials and methods: The fungistatic activities of chlorhexidine- and thymol-containing
mouth rinses were assessed by means of the minimum inhibitory concentration (MIC) and
the fungicidal activity was determined by a time-kill assay.
Results: The chlorhexidine-containing mouthwash was able to kill all strains of Candida albi-
cans and Candida tropicalis in shorter times compared to the thymol-containing mouthwash.
Hexidine showed an MIC of 1:32 for both Candida species, whereas Listerine respectively
showed MICs of 1:8 and 1:16 for C. albicans and C. tropicalis.
Conclusions: Antimicrobial agents used in the study had good in vitro activity against the two
Candida species. Mouth rinses containing chlorhexidine showed superior antifungal and fungi-
cidal activities compared to the thymol-containing mouth rinse. Both antimicrobial agents may
be suggested for use as topical antifungal agents.
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Candidiasis is the term used to denote infections caused by
species of Candida. The spectrum of disease caused by
Candida species includes infections of nails, skin, mucous
membranes, and internal organs. Although over 100 species
of Candida are recognized, not all are pathogenic to
humans. Important pathogenic species are Candida albi-
cans, Candida tropicalis, Candida parapsillosis, Candida
guilliermondi, Candida krusei, and Candida stellatoidea.
C. albicans is the most common pathogen of all Candida
species. Candida species are harmless commensals of the
human body and are a part of the normal flora of the
pharynx, intestine, vagina, perianal skin folds, and mouth.1
The dorsum of the tongue represents the primary oral
reservoir for these organisms, but mucosal surfaces and
dental plaque can also harbor them.2
Local or systemic factors must be involved for the
organism to become infectious because it was proven diffi-
cult to initiate experimentally produced Candida infections
in intact oral mucosa. Among precipitating factors are age,
depressed host defenses, endocrine disorders, heredity, ill-
fitting dentures, and protracted use of antibiotics, cortico-
steroids, or cytostatic drugs.3 When changes occur in host
defense mechanisms and the oral environment, yeasts may
induce mucosal and periodontal opportunistic infections.
The incidence of these infections has increased in parallel
with the increase in numbers of immunocompromised
patients, including HIV-infected individuals, transplant
recipients receiving immunosuppressive agents, and
patients undergoing cytotoxic chemotherapy and radio-
therapy for cancer and bone marrow transplantation.2
A number of antimycotic drugs are available for treating
oral candidiasis. Polyene antibiotics such as nystatin and
amphotericin B are among the recommended drugs.3 Mouth
rinses containing antimicrobial agents exert beneficial
clinical effects when used as adjuncts in treating peri-
odontal disease. Antibacterial activities and the effective-
ness in reducing or retarding plaque formation were
comprehensively studied.3 Furthermore, chlorhexidine
gluconate is also considered an appropriate adjunct or
alternative to specific antimycotic drugs, with administra-
tion of 0.2% chlorhexidine gluconate as a mouthwash being
widely recommended.2,4e6 Thymol is an essential oil which
is also used as a mouth rinse and was tested for its effect in
inhibiting the development of plaque and gingivitis.7
Studies were carried out to evaluate the antifungal effec-
tiveness of chlorhexidine gluconate and other antimicrobial
agents, such as sanguinarine, triclosan,2 aliphatic amines,8
and tetracycline hydrochloride.9 Chlorhexidine showed
superior antifungal effects except in studies involving
cetylpyridinium chloride6 and Listerine.7 The objective of
this study was to investigate the in vitro antifungal effect
of mouth rinses containing chlorhexidine and thymol.
Materials and methods
Specimen collection
Patients with signs of oral candidiasis were identified. As
a part of the diagnosis procedure in the Department of OralMedicine, Manipal College of Dental Sciences (MCODS),
Mangalore, sterile cotton swabs (2 each) were rolled and
pressed on the lesion to collect a specimen. Samples
obtained were immediately transported to the diagnostic
microbiological laboratory of the Department of Microbi-
ology, Kasturba Medical College, Mangalore. Samples were
subjected to further processing at the laboratory.
Microscopic examination
One of the swabs was used to prepare a smear on a clean
glass slide. The smear was air-dried, heat-fixed, and
stained by Gram’s method.10 The presence of many gram-
positive yeast cells with pseudo-hyphae was considered
significant.
Isolation and identification of Candida species
Candida species were isolated and identified using standard
methods. The second swab was used to inoculate Sabo-
roud’s dextrose agar (SDA). The inoculated medium was
incubated at 37C for up to 14 days. The colony morphology
of the fungal growth was examined. Candida species were
identified by the colony morphology, Gram’s stain, a germ
tube test, chlamydospore test, and sugar fermentation
layout.11
Study of the inhibitory effects of mouthwashes
against Candida
The present study is a portion of a larger study investigating
the in vitro and in vivo antifungal effects of various
prescribed antiseptic mouth rinses. Samples obtained from
oral candidiasis patients examined over a period of 6
months showed the presence of C. albicans and C. tropi-
calis in a ratio of 4:1. Hence, 4 isolates of C. albicans and 1
isolate of C. tropicalis were used in this study. The patients
from whom these isolates were sampled were free of
systemic disorders. Two male patients, 58 and 56 years old,
suffered from pseudomembranous candidiasis of the
dorsum of the tongue and 1 female patient, 52 years old,
suffered from pseudomembranous candidiasis of the soft
palate (Fig. 1). A 70-year-old female, wearing removable
complete dentures, had denture stomatitis along with
angular chelitis (Fig. 2). The fifth sample was taken from
a 45-year-old male who had median rhomboid glossitis with
an opposing palatal erythematous area.
Two commonly prescribed mouthwash products of
Hexidine (ICPA Health Products Ltd., Mumbai, Maharastra,
India) containing chlorhexidine and Listerine (Johnson &
Johnson Limited, Mumbai, Maharastra, India) containing
thymol, were procured from a local pharmacy. The anti-
fungal effects of the mouthwash proportions were studied
by a time-kill assay and broth dilution method.
Time-kill assay (suspension test)11
The test microorganisms in the mid-logarithmic growth
phase were inoculated into several tubes of broth con-
taining varying concentrations of mouthwash solutions and
a growth control tube without the drug. These tubes were
Figure 1 Clinical picture of oral candidiasis.
Antifungal effect of mouth rinses 3incubated at 35C. Then small aliquots were removed at
specific time intervals (of 0, 30, 60, 90, and 120 min),
diluted to obtain countable numbers of colonies and
plated onto agar for the colony count determinations. The
number of organisms remaining in each sample was
plotted over time to determine the rate of antimicrobial
agent killing.
Time-kill was defined as the shortest interval that yiel-
ded no growth or 1 discrete colony.Table 1 Time-kill assay (suspension test) results of
Hexidine and Listerine mouth rinses.Broth dilution method11
Two-fold serial dilutions each containing 1 mL of the anti-
microbial agent were prepared. Saboroud’s dextrose broth
(SDB) is the medium recommended for Candida species. A
standardized suspension of test bacteria was added to each
dilution to obtain a final bacterial concentration of
5  105 colony-forming units (cfu)/mL. A growth-control
tube (broth plus inoculum) and an uninoculated control
tube (broth only) were used with each test. After overnight
incubation at 35C, the minimum inhibitory concentration
(MIC) was determined visually as the lowest concentration
that inhibited growth as demonstrated by the absence of
turbidity.Figure 2 Clinical picture of denture stomatitis.Results
Intraoral swabs taken from patients exhibiting symptoms
of oral candidiasis were subjected to microscopic exami-
nation, isolation, and identification of Candida species.
Most of the specimen revealed C. albicans and the rest C.
tropicalis. C. albicans demonstrated true germ-tubes in
that there was continuation of the germ tubes from yeast
cells with no constriction at the junction between the yeast
cell and germ tube. C. tropicalis showed pseudo germ-
tubes, in that a constriction was present at the junction of
the yeast cell and germ tube.
In total, 5 strains of Candida were studied: 4 C. albicans
and 1 C. tropicalis. The time-kill assay and MIC procedures
to determine the antifungal effects of the 2 different types
of mouth rinses were carried out separately. The isolates
considered in this study were limited and not representa-
tive of the entire cohort of patients. Hence, statistical
analyses for significant results were not carried out.
Effect of mouthwashes
Table 1 shows the time-kill assay results for the chlorhex-
idine mouthwash. No colony of organisms of any of the 4
strains of C. albicans lasted beyond 30 min. C. tropicalis
showed a colony count for up to 60 min. The MIC of the
chlorhexidine-containing mouthwash was 1:32 (Table 2). As
for Listerine, all 4 strains of C. albicans were killed within
60 min. C. tropicalis showed a colony count for up to
90 min. The MIC was 1:8 for the C. albicans strains and 1:16
for the C. tropicalis strain.Discussion
This in vitro study to assess the antifungal activities of
chlorhexidine- and thymol-containing mouth rinses was
carried out by means of MIC and time-kill assays. The
results compared favorably with investigations by Giuliana
et al.2,12 However, the concentration of chlorhexidineMouthwash Candida species Time (min)
0 30 60 90 120
Colony count (cfu/mL)
Hexidine C. albicans (CA 1) 102 101 0 0 0
C. albicans (CA 2) 102 0 0 0 0
C. albicans (CA 3) 102 0 0 0 0
C. albicans (CA 4) 0 0 0 0 0
C. tropicalis (CT 1) 103 102 101 0 0
Listerine C. albicans (CA 1) 104 103 102 0 0
C. albicans (CA 2) 103 102 101 0 0
C. albicans (CA 3) 103 102 101 0 0
C. albicans (CA 4) 103 102 101 0 0
C. tropicalis (CT 1) 104 103 102 101 0
cfu, colony-forming units.
Table 2 Minimum inhibitory concentrations (MICs) of
Hexidine and Listerine mouth rinses.
Mouthwash Candida species MIC (dilution of
mouthwash)
Hexidine C. albicans (CA 1) 1:32
C. albicans (CA 2) 1:32
C. albicans (CA 3) 1:32
C. albicans (CA 4) 1:32
C. tropicalis (CT 1) 1:32
Listerine C. albicans (CA 1) 1:8
C. albicans (CA 2) 1:8
C. albicans (CA 3) 1:8
C. albicans (CA 4) 1:8
C. tropicalis (CT 1) 1:16
4 A. Shrestha et alrequired for growth inhibition of C. albicans was less than
that required for C. tropicalis.
The 0.2% chlorhexidine-containing mouthwash was able
to kill all strains of C. albicans in a shorter time compared
to the thymol-containing mouthwash. Similar results were
seen for C. tropicalis. However, both mouthwashes took
longer to kill the strain of C. tropicalis compared to
C. albicans. Studies conducted by Giuliana et al. showed
that the kill-time of mouth rinses containing chlorhexidine
were 180 seconds at half the concentration of commercial
formulations.2,8 No kill-times were achieved with the
sanguinarine-containing mouth rinse, and mouth rinses
containing either triclosan or hexetidine did not show
a lethal effect on C. albicans.2
As the current study was a pilot study, only standard
procedures of a time-kill assay were followed. However,
from a clinical standpoint, patients retain a mouth rinse
within the mouth for 30e60 seconds. A larger study,
involving more species of Candida and more varieties of
mouth rinses, should involve more-extensive testing and
more replicates of all isolates against all mouth rinses with
exposure times of 30, 45, and 60 seconds.
Time-kill studies to determine the period of exposure
needed to kill C. albicans were also performed with anti-
fungal drugs like amphotericin B and nystatin and compared
to chlorhexidine. A comparison showed that of the 3
agents, chlorhexidine had the most rapid killing effect on
this organism.6
The mode of action of chlorhexidine is not entirely
understood. However, some clues have emerged from
laboratory studies. The chlorhexidine molecule is a highly
cationic chlorophenyl bisbiguanide and avidly binds to
negatively charged surfaces including epithelial cells. In
addition, it was shown to adsorb onto enamel and salivary
proteins. It is therefore speculated that the crucial feature
of chlorhexidine is its substantivity in the oral cavity.
Indeed, about 30% of the total chlorhexidine dose may be
retained in the mouth for 24 hours after a 1-minute rinse,
although most of the agent is removed from the oral cavity
within the first hour. The slow and sustained release from
pellicle-covered oral surfaces appears to be an important
pharmacodynamic feature of chlorhexidine.13
Ultrastructural studies of Candida exposed to chlorhex-
idine showed coagulation of nucleoproteins with inhibitionof budding and cell wall changes with a possible escape of
cytoplasmic components through the plasmalemma.4 These
morphological events lead to death of some cells while cells
with previously protruding buds survived revealing a fungi-
cidal as well as a fungistatic effect of the antiseptic.13
The Listerine antiseptic acts as an essential oil-con-
taining antimicrobial mouth rinse. Its mode of action
against bacterial cells involves protein denaturation and
damage to the cell membrane, which results in leakage of
the intracellular components.4 Hence, thymol even when
used at high concentrations, in vitro, allows the uninhibited
growth of Candida, whereas chlorhexidine inhibits cell
growth and replication.
Conclusions
A study was carried out to assess the antifungal effects of
mouth rinses containing chlorhexidine and thymol. The
results indicated that the antimicrobial agents used in the
study have good in vitro activity against 2 Candida species.
Mouth rinses containing chlorhexidine showed superior
antifungal and fungicidal activities compared to the
thymol-containing mouth rinse. Both antimicrobial agents
can be suggested for use as topical antifungal agents. The
current study is an in vitro study involving only 2 species of
Candida and 2 different varieties of mouth rinses. A larger
study involving more species of Candida and more varieties
of mouth rinses is recommended. Continuity also needs to
be given to in vivo studies to justify the antifungal prop-
erties of the mouth rinses and their value in management of
oral candidiasis.References
1. Prabhu SR, Wilson DF, Daftary DK, Johnson NW, eds. Oral
Diseases in the Tropics, 1st ed. Oxford: Oxford University Press,
1992.
2. Giuliana G, Pizzo G, Milici ME, Musotto GC, Giangreco R. In
vitro antifungal properties of mouthrinses containing antimi-
crobial agents. J Periodontol 1997;68(8):729e33.
3. Barkvoll P, Attramadal A. Effect of nystatin and chlorhexidine
digluconate on Candida albicans. Oral Surg Oral Med Oral
Pathol 1989;67(3):279e81.
4. Meiller TF, Kelley JI, Jabra-Rizk MA, DePaola LG. In vitro
studies of the efficacy of antimicrobials against fungi. Oral
Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:663e70.
5. MacNeill S, Rindler E, Walker A, Brown AR, Cobb CM. Effects of
tetracycline hydrochloride and chlorhexidine gluconate on
Candida albicans: an in vitro study. J Clin Periodontol 1997;24:
753e60.
6. Hamers AD, Shay K, Hahn BL, Sohnle PG. Use of a microtiter
plate assay to detect the rate of killing of adherent Candida
albicans by antifungal agents. Oral Surg Oral Med Oral Pathot
Oral Radiol Endod 1996;81:44e9.
7. Anil S, Ellepola ANB, Samaranayake LP. The impact of chlo-
rhexidine gluconate on the relative cell surface hydrophobicity
of oral Candida albicans. Oral Dis 2001;7:119e22.
8. Pizzo G, Giuliana G. Antifungal activity of chlorhexidine con-
taining mouthrinses: an in vitro study. Minerva Stomatol 1998;
47(12):665e71.
9. Salem AM, Adams D, Newman HN, Rawle LW. Antimicrobial
properties of 2 aliphatic amines and chlorhexidine in vitro and
in saliva. J Clin Periodontol 1987;14:44e7.
Antifungal effect of mouth rinses 510. Duguid JP. Staining methods. In: Collee JG, Fraser AG,
Marmion BP, Simmons, eds. Mackie and McCartney Practical
Medical Microbiology, 14th ed. New York: Churchill Livingstone,
1996:796e9.
11. Mahon CR, Lehman DC, Mannselis G. Textbook of Diagnostic
Microbiology, 3rd ed. St Louis, Missourie: Saunders, 2007.12. Giuliana G, Pizzo G, Milici ME, Giangreco R. In vitro activities
of antimicrobial agents against Candida species. Oral Surg
Oral Med Oral Pathol Oral Radiol Endod 1999;87:44e9.
13. Ellepola ANB, Samaranayake LP. Adjunctive use of chlo-
rhexidine in oral candidoses: a review. Oral Dis 2001;7:
11e7.
